EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 2.5% of their position (44K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $5.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/5/2025ACC: 0001493152-25-009164
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+44K
Net shares
Net buyer
$5.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
44K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+44K
Price / share
$0.12
Trade value
$5.06K
% of position
2.5%
3/4/2025
1.76M→1.81M
Total
Net shares
+44K
Net value
$5.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2025 | P · Purchase | +44K | $0.12 | $5.06K | 2.5% | 1.76M | 1.81M |
| Total | +44K | $5.06K | ||||||
Derivative Transactions0
No derivative transactions reported